Markers to analyse the prescribing of non-steroidal anti-inflammatory drugs in ambulatory care: A guide to pursuing rational and safe prescribing

European Journal of Clinical Pharmacology

Volumn 55, Issue 6, 1999, Pages 479-486

  Schubert, I ^a   Ihle, P ^a   Koster I ^a   Von Ferber, L ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Internal quality assurance; NSAID prescribing; Quality markers

Indexed keywords

ANTACID AGENT; ANTIULCER AGENT; AZAPROPAZONE; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; OXYPHENBUTAZONE; PHENYLBUTAZONE; TIAPROFENIC ACID;

ADULT; AMBULATORY CARE; ARTICLE; DRUG CHOICE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

AMBULATORY CARE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; QUALITY CONTROL;

EID: 0032766496     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050660     Document Type: Article

References (47)

1. Rucker TD (1988) Pursuing rational drug therapy: a macro view à la the USA. J Soc Admin Pharm 5: 78-86
2. de Vries TPGM (1993) Presenting clinical pharmacology and therapeutics: general introduction. Br J Clin Pharmacol 35: 577-579
3. Britten N, Ukoumunne O (1997) The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ 315: 1506-1510
4. Bloor K, Freemantle N (1996) Lessons from international experience in controlling pharmaceutical expenditures. II. Influencing doctors. BMJ 312: 1525-1527
5. Raisch DW (1990) A model of methods influencing prescribing: Part II - A review of educational methods, theories of human inference, and delineation of the model. Drug Intell Clin Pharm 24: 537-541
6. Pursuing rational drug therapy. A symposium in print. J Soc Admin Pharm 5: 3/4, 1988
7. McGavock H (1991) Rational discussion as a guide to more cost-effective and scientific prescribing in general practice: 15 years of experiences in Northern Ireland. In: Kochen MM (ed) Rational pharmacotherapy in general practice. Springer, Berlin Heidelberg New York, pp 186-200
8. Wensing M, Grol R (1994) Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care 6: 115-132
9. Bateman DN, Eccles M, Campbell M, et al (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract 46: 20-25
10. Bakker A, Buurma H, Hekster YA, Leufkens HG (1997) Drug consumption in the Netherlands. Volume 2. Faculty of Pharmacy, Utrecht
11. Raisch DW (1990) A model of methods influencing prescribing: Part I - a review of prescribing models, persuasion theories, and administrative and educational methods. Drug Intell Clin Pharm 24: 417-421
12. Soumerai SB, McLaughlin TJ, Avorn J (1989) Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 67: 268-317
13. Von Ferber L, Alberti L, Köster I, Krappweis J (1992) Drug utilization research in primary health care as exemplified by physicians' quality assessment groups. Int J Clin Pharmacol 30: 453-455
14. Soumerai SB, Lipton HL (1994) Evaluating and improving physician prescribing. In: Strom B (ed) Pharmacoepidemiology (2nd edn) Wiley, Chichester, pp 395-412
15. Anderson GM, Lexchin J (1996) Strategies for improving prescribing practice. Can Med Assoc J 154: 1013-1017
16. von Ferber L (1993) Auditing drug therapy by peer review. The German experience. Pharmacoepidemiol Drug Saf 2: 195-200
17. von Ferber, L, Bausch J (1997) Qualitätssicherung durch Pharmakotherapiezirkel. Hess. Ärzteblatt 7: I-VIII
18. Schwabe U (1997) ATC Code edited by Wissenschaftliches Institut der AOK, Bonn
19. Guidelines for ATC classification and DDD assignment (1996) World Health Organization Collaboration Centre for Drug Statistics Methodology, Oslo
20. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, Sjöqvist F (1998) Drug utilization 90% - a simple method for assessing the quality of prescribing. Eur J Clin Pharmacol 54: 113-118
21. Popa C, Tomson Y, Engfeldt P, Bergman U (1997) Prescribing profiles as indicators for rational use of drugs. Abstract submitted to EACPT. Eur J Clin Pharmacol A 46, No. 69
22. Fish CA, Kirking DM, Martin JB (1992) Information systems for evaluating the quality of prescribing. Ann Pharmacother 26: 392-398
23. Schwabe U, Paffrath D (eds) Arzneiverordnungs-Report 1998. Springer, Berlin Heidelberg New York
24. Friebel H (1986) Arzneiverbrauch und Verordnungsprofile im internationalen und regionalen Vergeich. In: Doelle W, Mueller-Oerlinghausen B, Schwabe U (eds) Grundlagen der Arzneimitteltherapie. BI-Wissenschaftsverlag, Mannheim, pp 502-517
25. Göpel H (1986) Wirtschaftliche Arzneitherapie in der ärztlichen Praxis. In: Doelle W, Mueller-Oerlinghausen B, Schwabe U (eds) Grundlagen der Arzneimitteltherapie. BI-Wissenschaftsverlag, Mannheim, pp 492-501
26. Bundesminister für Arbeit und Sozialordnung (1990): Arzneimitteltransparenz und Arzneimittelberatung am Beispiel der Region Dortmund. Gesundheitsforschung Band 198, Bonn
27. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA (1995) A guide to good prescribing. A practical manual, World Health Organization Action Program on Essential Drugs, Geneva
28. Verband Forschender Arzneimittelhersteller e.V. Statistics (1997) Die Arzneimittelindustrie in Deutschland, Bonn
29. Melchert HU, Görsch B, Hoffmeister H (1995) Nichtstationäre Arzneimittelanwendung und subjektive Arzneimittelverträglichkeit in der bundesdeutschen Wohnbevölkerung der 25- bis 69jährigen. Ergebnisse der Erhebung des ersten nationalen Untersuchungs-Surveys 1984-1986. RKI-Schrift 1/95. MMV Medizin Verlag, München
30. Henry D, Lim L, Garcia Rodriguez LA, et al (1996) Variability in risk of gastrointestinal complications with individual nonsteroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312: 1563-1566
31. Miwa LJ, Jones JK, Pathiyl A, Hatoum H (1997) Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug story. Arch Intern Med 157: 2129-2136
32. Knapp DA (1991) Development of criteria for drug utilization review. Clin Pharmacol Ther 50: 601-602
33. de Vries C, Cusiel L, Sterneman AGM, Tromp TFJ, de Jong-van-den-Berg LTW (1998) Effects of peer review meetings on prescribing: a cohort study. In: De Vries C (ed) Collaboration in healthcare; the tango to drug safety. Proefschrift ter verkijging van het doctoraat in de Wiskunde en Natuurwetensschappen aan de Rijksuniversiteit Groningen, Doctoral thesis, University of Groningen, pp 133-143
34. A.T.I Arzneimittelinformation (1997) Positiv-telegramm 97. A.T.I. Arzneimittelinformation GmbH, Berlin
35. Verbraucher-Zentrale e.V. Hamburg, Baden-Württemberg et al (1996) Kieler Liste 1996. Notwendige Arzneimittel, Empfehlungen zum Arzneimittelgebrauch (2nd edn). Hamburg
36. Laporte JR, Carne X, Vidal X, et al (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 337: 278-284
37. Bateman DN (1994) NSAIDs: time to re-evaluate gut toxicity. Lancet 343: 1051-1052
38. Bateman DN, Kennedy JG (1995) Non-steroidal anti-inflammatory drugs and elderly patients. BMJ 310: 817-818
39. Langman MJ, Weil J, Wainwright P, et al (1994) Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 1075-1078
40. The Drug Utiliziation Research Unit (1995) Precision prescribing. Is it possible in General Practice? The five Commandments! Queens' University of Belfast
41. Roberts SJ, Bateman DN, Smith JM (1997) Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines. Br J Gen Pract 47: 13-17
42. Webb S, Lloyd M (1994) Prescribing and referral in general practice: a study on patients' expectations and doctors' actions. Br J Gen Pract 44: 165-169
43. Verspohl EJ (1991) Nichtsteroidale Antirheumatika. In: Ammon HPT (ed) Arzneimittelneben- und -Wechselwirkungen. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 423-466
44. Gracia Rodriguez LA, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769-772
45. Cardario B, McKinnon A (1991) Non-steroidal anti-inflammatory drugs. Monitoring to help prevent serious effects. Can Fam Physician 37: 171-180
46. Leufkens HG (1991) Utilization of nonsteroidal anti-inflammatory drugs in the Netherlands. In: Bakker A, Hekster YA, Leufkens HG (eds) Drug consumption in the Netherlands, pp 35-40
47. Phillips A, Polisson R, Simon L (1997) NSAIDs and the elderly. Drugs Aging, 2: 119-130